№ files_lp_4_process_3_090689
File format: docx Character count: 8251 File size: 24 KB
This document defines a collaborative practice agreement for rapid antigen testing of Group A beta-hemolytic streptococcus (GABHS) in community pharmacy settings, outlining patient eligibility, testing procedures, and treatment protocols.
Year: 2023
Region / City: Spokane, WA
Subject: Healthcare / Pharmacy Services
Document Type: Collaborative Practice Agreement
Institution: Pharmacy XXXXXX
Author: Dr. XXX
Target Audience: Pharmacists
Duration of Action: Ongoing
Approval Date: Not specified
Date of Last Revision: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Opinions about community pharmacy-based health screenings from patients’ living in Riyadh (Saudi Arabia), Poznan (Poland) and Chicago (United States of America)
Year: 2017
Region / city: Riyadh, Poznan, Chicago
Topic: Health screening in community pharmacies
Document type: Research article
Institution: Poznan University of Medical Sciences, Prince Sultan Military Medical City, Wegmans School of Pharmacy
Author: Magdalena Waszyk-Nowaczyk, Weronika Guzenda, Saif Alkathiri, Anna Ratka
Target audience: Healthcare professionals, researchers
Funding source: Poznan University of Medical Sciences
Period of validity: March 2016 – March 2017
Date of approval: Not provided
Date of modifications: Not provided
Topics: beta-hemolytic GABHS pharmacy-based